Differentiated thyroid carcinoma of children and adolescents

Endocrinologist

Volumn 12, Issue 2, 2002, Pages 135-142

  Bauer, Andrew J ^a   Tuttle, R Michael ^a   Francis, Gary L ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; RADIOACTIVE IODINE;

ALPHA CHAIN; CANCER MORTALITY; CANCER RISK; CHILDHOOD CANCER; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; GENE ACTIVATION; GENE MUTATION; HUMAN; NECK TUMOR; ONCOGENE RAS; ONCOGENE RET; RECURRENCE RISK; REVIEW; SURGICAL RISK; THYROID CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

EID: 0036193752     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200203000-00012     Document Type: Review

References (119)

1. Zur anstomie und klinik der struma maligna
2. Childhood thyroid carcinoma
3. Thyroid carcinoma and radiation. A Chicago endemic
4. A post-Chernobyl rise in thyroid cancer in Connecticut, USA
5. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987
6. Therapeutic radiation at a young age is linked to secondary thyroid cancer
7. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries
8. Nuclear accident
9. Chernobyl 7 years after the disaster. Increased number of thyroid cancer
10. Fallout from Chernobyl. Belarus increase was probably caused by Chernobyl
11. Thyroid cancer in Belarus post-Chernobyl: Improved detection or increased incidence?
12. Chernobyl-related thyroid cancer in children of Belarus: A case-control study
13. Chernobyl's thyroid cancer toll
14. Thyroid cancer in children in Belarus after Chernobyl
15. Childhood thyroid cancer following the Chernobyl accident: A status report
16. Cancer statistics, 1996
17. Thyroid cancer in children, pregnant women, and patients with Graves' disease
18. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults
19. Issues and epidemiological evidence regarding radiation-induced thyroid cancer
20. Follicular thyroid cancer
21. Follicular thyroid cancer: Prognosis
22. Thyroid cancer in childhood
23. Thyroid masses: Approach to diagnosis and management in childhood and adolescence
24. Solitary thyroid nodules in 71 children and adolescents
25. Thyroid palpation versus high-resolution thyroid ultrasonography in the detection of nodules
26. Characteristics of thyroid ultrasound pictures in children with nodular thyroid changes effected by radionuclides
27. High frequency of cancer in cold thyroid nodules occurring at young age
28. An analysis of fine-needle aspiration biopsy of the thyroid in children and adolescents
29. Pediatric thyroid nodules: Disease demographics and clinical management as determined by fine needle aspiration biopsy
30. Nodular thyroid disease and thyroid carcinoma
31. Thyroid cancer in children and adolescents
32. Ultrasound-guided fine-needle aspiration biopsy in the management of thyroid disease
33. Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinoma
34. Natural history, treatment, and course of papillary thyroid carcinoma
35. Thyroglobulin messenger ribonucleic acid levels in the peripheral blood of children with benign and malignant thyroid disease
36. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma
37. Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects
38. Telomere shortening is associated with cell division in vitro and in vivo
39. Recognition and elongation of telomeres by telomerase
40. Telomerase activity in human thyroid carcinomas originating from the follicular cells
41. Telomerase activity in lesions of the thyroid: Application to diagnosis of clinical samples including fine-needle aspirates
42. Telomerase activity in benign and malignant human thyroid tissues
43. Thyroid carcinomas that express telomerase follow a more aggressive clinical course for children and adolescents
44. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: A strong correlation between RET/PTC3 and the solid-follicular variant
45. Expression of wild-type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany
46. Molecular genetics of childhood papillary thyroid carcinomas after irradiation: High prevalence of RET rearrangement
47. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus
48. Low prevalence of the ret/PTC3r1 rearrangement in a series of papillary thyroid carcinomas presenting in Belarus ten years post-Chernobyl
49. The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus
50. Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation
51. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation
52. RET mutations in human disease
53. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident
54. The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults
55. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas
56. Activation of the ret/PTC oncogene in papillary thyroid cancer from Russian children exposed to radiation following the Chernobyl accident
57. Mechanisms of mutagenesis in mammalian cells. Application to human thyroid tumours
58. Thyroid carcinomas in RET/PTC transgenic mice
59. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: Implications for metastatic potential?
60. Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome
61. Molecular pathogenesis of thyroid nodules and cancer
62. Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours
63. Ras mutations are uncommon in sporadic thyroid cancer in children and young adults
64. N-ras mutation: An independent prognostic factor for aggressiveness of papillary thyroid carcinoma
65. Absence of G(s)alpha gene mutations in childhood thyroid tumors after Chernobyl in contrast to sporadic adult thyroid neoplasia
66. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults
67. Clinical relevance of vascular endothelial growth factor for thyroid neoplasms
68. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer
69. Vascular endothelial growth factor (VEGF) and Type 1 VEGF receptor (Flt-1) are highly expressed in Russian papillary thyroid carcinomas
70. Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma
71. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma
72. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults
73. Current trends in the management of well differentiated papillary thyroid carcinoma
74. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer
75. Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases
76. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry
77. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma
78. Total thyroidectomy: The treatment of choice for patients with differentiated thyroid cancer
79. Different features of pulmonary metastases in differentiated thyroid cancer: Natural history and multivariate statistical analysis of prognostic variables
80. Improved survival of patients with papillary thyroid cancer after surgical microdissection
81. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer
82. Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer
83. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer
84. The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients
85. Differentiated and medullary thyroid cancer in children and adolescence
86. Thyroid neoplasia in children
87. Differentiated thyroid carcinoma in children and adolescents
88. Thyroid cancer in children and adolescents
89. Differentiated thyroid carcinoma in childhood: Long-term follow-up of 72 patients
90. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer
91. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer
92. The usefulness of iodine-123 whole-body scans in evaluating thyroid carcinoma and metastases
93. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma
94. Sodium/iodide symporter: A key transport system in thyroid cancer cell metabolism
95. Thymus accumulation of radioactive iodine
96. Recombinant human thyrotropin
97. Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group
98. Radioiodine treatment of thyroid cancer
99. Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer
100. Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas
101. Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: Potential risks and recommendations
102. Outcome of pregnancy following treatment of well-differentiated thyroid cancer with 131 iodine
103. Iodine 131 thyroid ablation in female children and adolescents: Long-term risk of infertility and birth defects
104. Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer
105. Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogue
106. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels
107. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma
108. F-18-fluorodeoxyglucose positron emission tomography as a presurgical evaluation modality for I-131 scan-negative thyroid carcinoma patients with local recurrence in cervical lymph nodes
109. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan
110. Pinhole SPECT imaging in normal and morbid ankles
111. Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan
112. Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer
113. An approach to the management of patients with scan negative, thyroglobulin positive, differentiated thyroid cancer: Alternative imaging procedures
114. Papillary microcancer of the thyroid
115. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study
116. Geographic pathology of occult thyroid carcinomas
117. Prevalence and significance of occult thyroid cancer
118. Regulation of the sodium/iodide symporter by retinoids: A review
119. Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma